Malignant Peritoneal Neoplasm Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02865811Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal CancerTreatment